Palifermin, a recombinant human keratinocyte growth factor, triggers reactivation of anogenital human papillomavirus infection in a HIV-positive patient with diffuse large cell B-cell non-Hodgkin lymphoma

Bone Marrow Transplant. 2009 Dec;44(12):823-4. doi: 10.1038/bmt.2009.81. Epub 2009 May 4.

Authors

T Schroeder, F Zohren, C Saure, G Kobbe, R Haas

PMID: 19421177
DOI: 10.1038/bmt.2009.81

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Alphapapillomavirus*
Condylomata Acuminata* / chemically induced
Condylomata Acuminata* / pathology
Condylomata Acuminata* / therapy
Condylomata Acuminata* / virology
Fibroblast Growth Factor 7 / administration & dosage
Fibroblast Growth Factor 7 / adverse effects*
HIV Seropositivity* / complications
HIV Seropositivity* / pathology
HIV Seropositivity* / therapy
HIV Seropositivity* / virology
Humans
Lymphoma, Large B-Cell, Diffuse* / complications
Lymphoma, Large B-Cell, Diffuse* / pathology
Lymphoma, Large B-Cell, Diffuse* / therapy
Lymphoma, Large B-Cell, Diffuse* / virology
Male
Stomatitis / prevention & control

Substances

Fibroblast Growth Factor 7